Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q3 2023 Earnings Conference Call. At this time, participants are in a listen-only mode.

Related Keywords

Germany ,United States ,Canada ,Netherlands ,Japan ,Italy ,Spain ,United Kingdom ,Pushkal Garg ,Yvonne Greenstreet ,Paul Matteis ,Tolga Tanguler ,Christine Lindenboom ,Jeff Poulton ,Drug Administration ,Novartis ,Alnylam Pharmaceuticals ,Nasdaq ,Alnylam Pharmaceuticals Inc ,Corporate Communications At Alnylam ,Call Transcript November ,Senior Vice President ,Investor Relations ,Corporate Communications ,Chief Executive Officer ,Chief Commercial Officer ,Chief Medical Officer ,Chief Financial ,Safe Harbor ,Private Securities Litigation Reform Act ,Thanks Christine ,New Drug Application ,Advisory Committee Meeting ,New England Journal ,Science Magazine ,Annual Rd Day ,Market Access ,Disease Conference ,Fitness Apps ,Performing Disney Animated Movies ,Ritu Baral ,